Genmab A/S (GMAB)
30.06
-0.54
(-1.78%)
USD |
NASDAQ |
Feb 11, 16:00
30.06
0.00 (0.00%)
After-Hours: 20:00
Genmab Market Cap : 18.48B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 390.33B |
| Krystal Biotech, Inc. | 7.897B |
| Novo Nordisk A/S | 216.69B |
| Ascendis Pharma A/S | 13.51B |
| Zealand Pharma A/S | 4.487B |
Market Cap Related Metrics
| PE Ratio | 12.76 |
| PS Ratio | 5.261 |
| PEG Ratio | 0.1007 |
| Price to Book Value | 3.214 |
| Price to Free Cash Flow | 15.55 |
| Price | 30.06 |
| Earnings Yield | 7.84% |
| PEGY Ratio | 0.1007 |
| Operating PE Ratio | 14.28 |
| Normalized PE Ratio | 12.70 |